(S)-4-(3-bromophenyl)-6,8-dichloro-2-methyl-1,2,3,4-tetrahydroisoquinoline
98%
- Product Code: 126383
CAS:
1870821-29-6
| Molecular Weight: | 371.10 g./mol | Molecular Formula: | C16H14BrCl2N |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD27939616 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C, sealed, dry |
Product Description:
This compound is primarily utilized in pharmaceutical research and development, particularly in the study of central nervous system (CNS) disorders. Its structural features make it a potential candidate for targeting specific receptors or enzymes involved in neurological pathways. Researchers explore its efficacy in modulating neurotransmitter activity, which could lead to the development of novel treatments for conditions such as depression, anxiety, or neurodegenerative diseases. Additionally, its unique chemical structure allows for further derivatization, enabling the creation of analogs with optimized pharmacological properties. It is also investigated for its potential role in pain management and as a tool compound in preclinical studies to understand disease mechanisms.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | Light Yellow to Yellow Solid |
| Purity (%) | 97.5-100 |
| Infrared Spectrum | Conforms to Structure |
| NMR | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | £191.11 |
+
-
|
| 0.250 | 10-20 days | £319.80 |
+
-
|
| 1.000 | 10-20 days | £652.27 |
+
-
|
(S)-4-(3-bromophenyl)-6,8-dichloro-2-methyl-1,2,3,4-tetrahydroisoquinoline
This compound is primarily utilized in pharmaceutical research and development, particularly in the study of central nervous system (CNS) disorders. Its structural features make it a potential candidate for targeting specific receptors or enzymes involved in neurological pathways. Researchers explore its efficacy in modulating neurotransmitter activity, which could lead to the development of novel treatments for conditions such as depression, anxiety, or neurodegenerative diseases. Additionally, its unique chemical structure allows for further derivatization, enabling the creation of analogs with optimized pharmacological properties. It is also investigated for its potential role in pain management and as a tool compound in preclinical studies to understand disease mechanisms.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
£0.00
£0.00
Total :